SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals informs about disclosure

05 Jun 2026 Evaluate
SMS Pharmaceuticals has informed that the Company had received a request from a shareholder holding shares in physical form for updating KYC documents through the Registrar and Share Transfer Agent (RTA) of the Company. Upon verification of the KYC documents submitted by the shareholder, the Company observed that the said shares had already been claimed by another person impersonating the original shareholder. Accordingly, the Company initiated a detailed enquiry and carried out verification of the documents and transfer records relating to the said shares.

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

368.75 14.95 (4.23%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×